Abstract
 Objective: The aim of this study is to report the survival and treatment results patients with cervical esophageal cancer treated definitive chemoradiotherapy, whose incidence very low in population there not enough information about toxicity literature. 
 Material Method: Between 2013 2022, 10 (six males four females) chemoradiotherapy were included. Among these patients, s...

AIM To evaluate the efficacy and toxicity of preoperative chemoradiotherapy with capecitabine in locally advanced rectal cancer. METHODS Between June 2004 and January 2005, 57 patients with operable, clinical stage II-III adenocarcinoma of the rectum entered the prospective phase II study. Radiation dose was 45 Gy (25x1.8 Gy). Concurrent chemotherapy with a daily dose of 1650 mg/m2 capecitabi...

BACKGROUND The role of contemporary radiotherapy (RT) has not yet been elucidated, mainly because of the low incidence of cervical esophageal cancer. The purpose of this study was to analyze the outcome in patients with cervical esophageal cancer treated with definitive RT. METHODS A total of 115 patients with cervical esophageal cancer treated with definitive RT during January 2001 through A...

BACKGROUND The main concerns with radiation therapy for head and neck cancer in human immunodeficiency virus (HIV)-infected patients include limited tumor response and profound mucosal or skin toxicities under severe immunocompromised status. METHODS In this study, we describe the clinicopathological features, chronological changes in HIV viral loads and CD4 counts, and treatment outcomes of ...

In patients with adult soft-tissue sarcoma (ASTS), the use and timing of adjuvant chemotherapy or chemoradiotherapy remains controversial. The appropriate target population is generally accepted as International Union Against Cancer (UICC)/American Joint Committee on Cancer (AJCC) stage III extremity or trunk sarcomas (i.e., >5 cm, grade 3/4, located deep to the superficial fascia, with no evid...

BACKGROUND The survival benefit of adjuvant chemotherapy alone or chemoradiotherapy in patients with pancreatic cancer who have undergone surgical resection remains unclear. OBJECTIVE To identify the additional benefit of adjuvant therapy by retrospectively examining a large population-based registry of patients who underwent definitive surgical resection for pancreatic adenocarcinoma. DESI...

Background: Esophageal cancer is a malignancy with poor survival rate, and the optimal management of esophageal patients still controversial. This study aimed to compare one-year who had received definitive chemoradiotherapy (DCRT) or neoadjuvant plus surgery (NCRT+S). Materials Methods: In this cross-sectional descriptive study, medical records were extracted from 2018 2019; last status was ob...